RT @EAntonarakis: Congrats @eamontoye13 and @arafflemd on your 2 recent papers studying BRAF alterations in PCa. Unlike other BRAF-altered…
RT @EAntonarakis: Congrats @eamontoye13 and @arafflemd on your 2 recent papers studying BRAF alterations in PCa. Unlike other BRAF-altered…
RT @EAntonarakis: Congrats @eamontoye13 and @arafflemd on your 2 recent papers studying BRAF alterations in PCa. Unlike other BRAF-altered…
RT @EAntonarakis: Congrats @eamontoye13 and @arafflemd on your 2 recent papers studying BRAF alterations in PCa. Unlike other BRAF-altered…
On July 16, 2024, Oncotarget #published a new #research perspective, entitled, "Targeting the multifaceted BRAF in cancer: New directions." https://t.co/BQF18egVvw #cancer #quote #genomics #perspective #spotlight #paperspotlight #trending #oa #journal #p
Watch an #oncotargetshort #video of this #research perspective: "Targeting the multifaceted BRAF in cancer: New directions." @UMNews @Penn @cityofhope https://t.co/BQF18egVvw #cancer #paperspotlight #genomics #perspective #oa #peerreview #journal #public
Targeting the multifaceted BRAF in cancer: New directions - https://t.co/8VHWu9RbhN
Targeting the multifaceted BRAF in cancer: New directions https://t.co/UCFuymgtgC
#PaperoftheDay: "Targeting the multifaceted BRAF in cancer: New directions" DOI ⬇️ https://t.co/BQF18egVvw #cancer #research #openaccess #peerreviewed #publishing
NEW #PaperoftheDay: "Targeting the multifaceted BRAF in cancer: New directions" DOI ⬇️ https://t.co/BQF18egVvw
RT @EAntonarakis: Congrats @eamontoye13 and @arafflemd on your 2 recent papers studying BRAF alterations in PCa. Unlike other BRAF-altered…
RT @EAntonarakis: Congrats @eamontoye13 and @arafflemd on your 2 recent papers studying BRAF alterations in PCa. Unlike other BRAF-altered…
RT @EAntonarakis: Congrats @eamontoye13 and @arafflemd on your 2 recent papers studying BRAF alterations in PCa. Unlike other BRAF-altered…
RT @EAntonarakis: Congrats @eamontoye13 and @arafflemd on your 2 recent papers studying BRAF alterations in PCa. Unlike other BRAF-altered…
RT @EAntonarakis: Congrats @eamontoye13 and @arafflemd on your 2 recent papers studying BRAF alterations in PCa. Unlike other BRAF-altered…
RT @EAntonarakis: Congrats @eamontoye13 and @arafflemd on your 2 recent papers studying BRAF alterations in PCa. Unlike other BRAF-altered…
RT @EAntonarakis: Congrats @eamontoye13 and @arafflemd on your 2 recent papers studying BRAF alterations in PCa. Unlike other BRAF-altered…
RT @EAntonarakis: Congrats @eamontoye13 and @arafflemd on your 2 recent papers studying BRAF alterations in PCa. Unlike other BRAF-altered…
RT @EAntonarakis: Congrats @eamontoye13 and @arafflemd on your 2 recent papers studying BRAF alterations in PCa. Unlike other BRAF-altered…
RT @EAntonarakis: Congrats @eamontoye13 and @arafflemd on your 2 recent papers studying BRAF alterations in PCa. Unlike other BRAF-altered…
RT @EAntonarakis: Congrats @eamontoye13 and @arafflemd on your 2 recent papers studying BRAF alterations in PCa. Unlike other BRAF-altered…
Congrats @eamontoye13 and @arafflemd on your 2 recent papers studying BRAF alterations in PCa. Unlike other BRAF-altered cancers, PCa is characterized by Class II muts and activating fusions, including AR-regulated BRAF fusions. https://t.co/GnCf0kH4TQ